BriaCell Therapeutics
BCTX----
Q3 FY2026 Earnings
Financial report interval: 2026.01.30 - 2026.04.30
Overview: BriaCell Therapeutics(BCTX) the EBIT is -7.621 M (-20.42%);the EPS is -0.99 (+93.97%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.01B20.42%
----
----
EPS
-0.9993.97%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf